↓ Skip to main content

Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?

Overview of attention for article published in Annals of General Psychiatry, January 2011
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
41 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?
Published in
Annals of General Psychiatry, January 2011
DOI 10.1186/1744-859x-10-8
Pubmed ID
Authors

Konstantinos N Fountoulakis, Xenia Gonda, Eduard Vieta, Zoltan Rihmer

Abstract

Anecdotal reports suggests that most clinicians treat medications as belonging to a class with regard to all therapeutic indications; this means that the whole 'class' of drugs is considered to possesses a specific therapeutic action. The present article explores the possible existence of a true 'class effect' for agents available for the treatment of bipolar disorder.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 2%
United States 1 2%
Canada 1 2%
Unknown 38 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 27%
Student > Postgraduate 6 15%
Other 5 12%
Student > Master 4 10%
Professor > Associate Professor 3 7%
Other 12 29%
Readers by discipline Count As %
Medicine and Dentistry 22 54%
Psychology 10 24%
Agricultural and Biological Sciences 5 12%
Unspecified 3 7%
Social Sciences 1 2%
Other 0 0%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2014.
All research outputs
#3,534,128
of 4,506,837 outputs
Outputs from Annals of General Psychiatry
#162
of 209 outputs
Outputs of similar age
#83,840
of 107,147 outputs
Outputs of similar age from Annals of General Psychiatry
#9
of 11 outputs
Altmetric has tracked 4,506,837 research outputs across all sources so far. This one is in the 2nd percentile – i.e., 2% of other outputs scored the same or lower than it.
So far Altmetric has tracked 209 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,147 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.